@inproceedings{inproceedings, title  = {{IMMUNO-MODULATION IN AMYOTROPHIC LATERAL SCLEROSIS - A PHASE II STUDY OF SAFETY AND ACTIVITY OF LOW DOSE INTERLEUKIN-2 (IMODALS study) (S3.006)}},

 publisher = {{Ovid Technologies (Wolters Kluwer Health)}},

 url = {{https://doi.org/10.1212/wnl.88.16_supplement.s3.006 }},

 year = {{2017}},

 month = {{4}},

 author = {{Bensimon G and Camu W and Payan C and Tree T and Veyrune J-L and Malaspina A and Garlanda C and Locati M and Saker S and Juntas-Morales R and Pageot N et al}},

 doi = {{10.1212/wnl.88.16_supplement.s3.006}},

 volume = {{88}},

 journal = {{Neurology}},

 issue = {{16_supplement}},

 note = {{Accessed on 2025/11/22}}}